Lannett Kicks Off Insulin Glargine Trial

Firm Eyes 2023 Filing And 2024 Launch For US Interchangeable Biosimilar Lantus Rival

 
• By Dave Wallace
  
Road years 2022 2023 2024
The road to an insulin glargine launch stretches to 2024 for Lannett • Source: thodsapol thongdeekhieo / Alamy Stock Photo

More from Biosimilars

More from Products